Effects of simvastatin on glucose metabolism in mouse MIN6 cells

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Zhou, Jieqiong ^a   Li, Weihua ^a   Xie, Qiang ^a   Hou, Yuxi ^a   Zhan, Shaopeng ^a   Yang, Xi ^a   Xu, Xiaofeng ^a   Cai, Jun ^b   Huang, Zhengrong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 2; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MESSENGER RNA; SIMVASTATIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL 1.2; ADENOSINE TRIPHOSPHATE; ANTILIPEMIC AGENT; CACNA1C PROTEIN, MOUSE; CALCIUM CHANNEL L TYPE; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM; SLC2A2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE METABOLISM; HORMONE INHIBITION; INSULIN RELEASE; MIN6 CELL LINE; MOUSE; NONHUMAN; POTASSIUM CURRENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP; ANALYSIS; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PANCREAS ISLET BETA CELL; PATCH CLAMP TECHNIQUE; RADIOIMMUNOASSAY; SECRETION (PROCESS);

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GLUCOSE; CALCIUM CHANNELS, L-TYPE; CELL LINE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; HYPOLIPIDEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; PATCH-CLAMP TECHNIQUES; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RADIOIMMUNOASSAY; REAL-TIME POLYMERASE CHAIN REACTION; SIMVASTATIN;

EID: 84903625140     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/376570     Document Type: Article

References (17)

1. Sever P. S., Dahlöf B., Poulter N. R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S. E., Kristinsson A., McInnes G. T., Mehlsen J., Nieminen M., O'Brien E., Östergren J., Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. The Lancet 2003 361 9364 1149 1158 2-s2.0-0037420492 10.1016/S0140-6736(03)12948-0 (Pubitemid 36398384)
2. Emberson J., Holland L. E., Reith C., Bhala N., Peto R., Barnes E. H., Keech A., Simes J., Collins R., Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. The Lancet 2010 376 9753 1670 1681 10.1016/S0140-6736(10) 61350-5
3. Smith S. C. Jr., Allen J., Blair S. N., Bonow R. O., Brass L. M., Fonarow G. C., Grundy S. M., Hiratzka L., Jones D., Krumholz H. M., Mosca L., Pasternak R. C., Pearson T., Pfeffer M. A., Taubert K. A., AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the national heart, lung, and blood Institute. The American College of Cardiology 2006 47 10 2130 2139 2-s2.0-33646828142 10.1016/j.jacc.2006.04.026 (Pubitemid 44275145)
4. Grundy S. M., Cleeman J. I., Merz C. N., Brewer H. B. Jr., Clark L. T., Hunninghake D. B., Pasternak R. C., Smith S. C. Jr., Stone N. J., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004 110 2 227 239 2-s2.0-3142729178 10.1161/01.CIR.0000133317.49796.0E (Pubitemid 38924592)
5. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). The Journal of the American Medical Association 2001 285 19 2486 2497 10.1001/jama.285.19.2486 2-s2.0-0035897696 (Pubitemid 32433843)
6. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., Dallongeville J., De Backer G., Ebrahim S., Gjelsvik B., Herrmann-Lingen C., Hoes A., Humphries S., Knapton M., Perk J., Priori S. G., Pyorala K., Reiner Z., Ruilope L., Sans-Menendez S., Scholte Op Reimer W., Weissberg P., Wood D., Yarnell J., Zamorano J. L., European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European Heart Journal 2007 28 19 2375 2414 2-s2.0-35148892823 10.1093/eurheartj/ehm316 (Pubitemid 47542237)
7. Preiss D., Seshasai S. R., Welsh P., Murphy S. A., Ho J. E., Waters D. D., DeMicco D. A., Barter P., Cannon C. P., Sabatine M. S., Braunwald E., Kastelein J. J. P., De Lemos J. A., Blazing M. A., Pedersen T. R., Tikkanen M. J., Sattar N., Ray K. K., Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. The Journal of the American Medical Association 2011 305 24 2556 2564 2-s2.0-79959428660 10.1001/jama.2011.860
8. Rajpathak S. N., Kumbhani D. J., Crandall J., Barzilai N., Alderman M., Ridker P. M., Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Diabetes Care 2009 32 10 1924 1929 2-s2.0-70349664292 10.2337/dc09-0738
9. Sattar N., Preiss D., Murray H. M., Welsh P., Buckley B. M., de Craen A. J., Seshasai S. R. K., McMurray J. J., Freeman D. J., Jukema J. W., Macfarlane P. W., Packard C. J., Stott D. J., Westendorp R. G., Shepherd J., Davis B. R., Pressel S. L., Marchioli R., Marfisi R. M., Maggioni A. P., Tavazzi L., Tognoni G., Kjekshus J., Pedersen T. R., Cook T. J., Gotto A. M., Clearfield M. B., Downs J. R., Nakamura H., Ohashi Y., Mizuno K., Ray K. K., Ford I., Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. The Lancet 2010 375 9716 735 742 2-s2.0-77549087054 10.1016/S0140- 6736(09)61965-6
10. Nakata M., Nagasaka S., Kusaka I., Matsuoka H., Ishibashi S., Yada T., Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia 2006 49 8 1881 1892 2-s2.0-33745794259 10.1007/s00125-006-0269-5 (Pubitemid 44025043)
11. Bentinger M., Tekle M., Dallner G., Coenzyme Q-biosynthesis and functions. Biochemical and Biophysical Research Communications 2010 396 1 74 79 2-s2.0-77952300148 10.1016/j.bbrc.2010.02.147
12. Berthold H. K., Naini A., Di Mauro S., Hallikainen M., Gylling H., Krone W., Gouni-Berthold I., Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial. Drug Safety 2006 29 8 703 712 2-s2.0-33746848052 10.2165/00002018-200629080-00007 (Pubitemid 44175041)
13. Kawashiri M. A., Nohara A., Tada H., Mori M., Tsuchida M., Katsuda S., Inazu A., Kobayashi J., Koizumi J., Mabuchi H., Yamagishi M., Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study. Clinical Pharmacology and Therapeutics 2008 83 5 731 739 2-s2.0-42349116146 10.1038/sj.clpt.6100396 (Pubitemid 351556020)
14. Chu C. S., Kou H. S., Lee C. J., Lee K. T., Chen S. H., Voon W. C., Sheu S. H., Lai W. T., Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia. BioFactors 2006 28 3-4 177 184 2-s2.0-34250354742
15. Watts G. F., Castelluccio C., Rice-Evans C., Tabu N. A., Baum H., Quinn P. J., Plasma coenzyme Q (Ubiquinone) concentrations in patients treated with simvastatin. Journal of Clinical Pathology 1993 46 11 1055 1057 2-s2.0-0027379891 (Pubitemid 23349243)
16. Taneja T. K., Mankouri J., Karnik R., Kannan S., Smith A. J., Munsey T., Christesen H. B. T., Beech D. J., Sivaprasadarao A., Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism. Human Molecular Genetics 2009 18 13 2400 2413 2-s2.0-67249102334 10.1093/hmg/ddp179
17. Moritz W., Leech C. A., Ferrer J., Habener J. F., Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic β -cells. Endocrinology 2001 142 1 129 138 2-s2.0-0035114908 10.1210/endo.142.1.7885 (Pubitemid 32183674)